Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $582.62 | 52 | 87.1% |
| Education | $86.49 | 1 | 12.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $302.22 | 36 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $153.04 | 5 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $98.78 | 5 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $35.09 | 2 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $18.79 | 1 | $0 (2021) |
| Almatica Pharma LLC | $16.90 | 1 | $0 (2023) |
| Ironshore Pharmaceuticals Inc. | $16.58 | 1 | $0 (2022) |
| Neos Therapeutics, LP | $15.63 | 1 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $12.08 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57.84 | 3 | Supernus Pharmaceuticals, Inc. ($40.79) |
| 2023 | $210.29 | 22 | ABBVIE INC. ($152.86) |
| 2022 | $63.75 | 4 | Vanda Pharmaceuticals Inc. ($35.09) |
| 2021 | $337.23 | 24 | AbbVie Inc. ($149.36) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/29/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/28/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Neurology | ||||||
| 12/22/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.31 | General |
| Category: PSYCHOLOGY | ||||||
| 11/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.14 | General |
| Category: PSYCHOLOGY | ||||||
| 10/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Central Nervous System | ||||||
| 06/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2023 | Almatica Pharma LLC | SERTRALINE HCL (Drug), LOREEV XR | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: ANTI-DEPRESSION | ||||||
| 02/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 12 | 12 | $2,220 | $581.88 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 12 | $2,220 | $581.88 | 26.2% |
About Resheda House
Resheda House is a Psychiatric/Mental Health healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2013. The National Provider Identifier (NPI) number assigned to this provider is 1790026706.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Resheda House has received a total of $669.11 in payments from pharmaceutical and medical device companies, with $57.84 received in 2024. These payments were reported across 53 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($582.62).
As a Medicare-enrolled provider, House has provided services to 12 Medicare beneficiaries, totaling 12 services with total Medicare billing of $581.88. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Family
- Location Pittsburgh, PA
- Active Since 03/15/2013
- Last Updated 09/23/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1790026706
Products in Payments
- VRAYLAR (Drug) $302.22
- Qelbree (Drug) $40.79
- AUSTEDO (Drug) $36.42
- HETLIOZ (Drug) $35.09
- QELBREE (Drug) $27.45
- Nuedexta (Drug) $18.79
- UZEDY (Drug) $17.05
- SERTRALINE HCL (Drug) $16.90
- JORNAY PM (Drug) $16.58
- Adzenys XR-ODT (Drug) $15.63
- Austedo XR (Drug) $13.08
- LATUDA (Drug) $12.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Pittsburgh
Britney Scolieri, Dnp, Pmhnp-Bc, DNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $112,057
Ashley Wood, Crnp Pmhnp, CRNP PMHNP
Psychiatric/Mental Health — Payments: $4,796
Dr. Joshua Palmer, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $4,230
Dr. Danielle Dipre, Phmnp-Bc Dnp, PHMNP-BC DNP
Psychiatric/Mental Health — Payments: $1,864
Dr. Brad Burns, Dnp, Pmhnp-Bc, DNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,848
Jerrod Nestor
Psychiatric/Mental Health — Payments: $1,771